All In MedTech

Device Trial Radar · NCT03213210

Efficacy of Synthetic Bone Graft for Treatment of Peri-implantitis

Clinical Efficacy of Easy-graft CLASSIC for the Treatment of Peri-implantitis

Last checked: Nov 19, 2026Latest source record: Apr 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

5

Actual

Start

Nov 12, 2018

Primary completion

Dec 31, 2019

Study completion Jan 31, 2020

Sponsor

Lead sponsor
Sunstar AmericasNot on our public-company list
Sponsor type
Industry
First posted
Jul 11, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Single arm study to evaluate the effectiveness of treatment approach using a new moldable beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in peri-implantitis.

Conditions

  • Peri-Implantitis

Interventions

  • easy-graft CLASSIC (beta-Tricalcium Phosphate)Device

    easy-graft will be grafted to the bone defect supporting a dental implant and covered by polylactide membrane to facilitate regeneration of new bone and healthy attachment to stabilize the dental implant.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Probing DepthTime frame: Change from baseline at 12 months after the surgery
  2. Esthetic SatisfactionTime frame: At 12 months after the surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Creighton University School of Dentisty

    Omaha, Nebraska

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.